Generic Exforge HCT

There are currently no generic versions of Exforge HCT (amlodipine-valsartan-hydrochlorothiazide) licensed for sale in the United States. The first patent for this medication is set to expire in September 2012. This is the earliest possible date that any generic manufacturers could produce a generic Exforge HCT product.

Exforge HCT Medication Information

Is a Generic Version of Exforge HCT Available?

Exforge HCT^® (amlodipine-valsartan-hydrochlorothiazide) is a prescription medication used to treat high blood pressure (known medically as hypertension). It contains three different blood pressure medications combined in a single tablet.

Exforge HCT is made by Novartis Pharmaceuticals Corporation. It is currently under the protection of a patent that prevents any generic Exforge HCT from being manufactured in the United States.

When Will a Generic Version Be Available?

The first patent for Exforge HCT is currently set to expire in September 2012. This is the earliest predictable date that a generic version of Exforge HCT could become available. However, there are other circumstances that could come up to extend or shorten the exclusivity period of Exforge HCT. This could include such things as other patents for specific Exforge HCT uses or lawsuits.

Once Exforge HCT goes off patent, there may be several companies that will begin manufacturing a generic Exforge HCT drug.

Exforge HCT: A Combination Medication

Exforge HCT contains three medications:

amlodipine (Norvasc^®), valsartan (Diovan^®), and hydrochlorothiazide. While amlodipine and hydrochlorothiazide are available in generic versions, valsartan is not.

For many people (depending on insurance coverage), it is less expensive to take Exforge HCT rather than the three medications separately, and you will benefit from the convenience of taking one tablet daily, rather than three.